Bank of America
BEAM icon

Bank of America’s Beam Therapeutics BEAM Stock Holding History

Bank of America’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11,900
Closed -$1.53M – 8103
2021
Q2 		$1.53M Buy
+11,900
New +$948K ﹤0.01% 4535

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Bank of America's BEAM Position: Q1 2026 in Review

Bank of America increased its Beam Therapeutics (BEAM) stake by 26% in Q1 2026, buying an estimated $3.08M and bringing the position to 538,290 shares worth $12.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2763.

Bank of America first reported a position in BEAM in Q1 2020 and has held it in 25 quarters since. The position peaked at $18.9M in Q3 2025. 252 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Bank of America held 538,290 shares of Beam Therapeutics worth $12.8M as of Q1 2026.
  • Bank of America bought 110,962 Beam Therapeutics shares in Q1 2026, an estimated $3.08M.
  • Beam Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2763 holding.
  • Bank of America first reported a position in Beam Therapeutics in Q1 2020 and has held it in 25 quarters since.
  • Bank of America's Beam Therapeutics position peaked at $18.9M in Q3 2025.
  • 252 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.